Prolonged β-Agonist Infusion Does Not Induce Desensitization or Down-Regulation of β-Adrenergic Receptors in Newborn Sheep

H. Stein,K. Oyama,R. Sapién,B. A,J. Padbury
DOI: https://doi.org/10.1203/00006450-199205000-00009
IF: 3.953
1992-05-01
Pediatric Research
Abstract:ABSTRACT: In adult animals, prolonged β-agonist expo-sore leads to down-regulation of β-adrenergic receptors and deseasitization. Prior evidence from our lab suggests that this may not occur in developing animals. To study this, we measured the response to graded epinephrine infusion [2.7, 5.5,13.6, 273 μmol(kg · min), (0.5, 1.0, 2.5, 5.0 μg/ (kg · mm)], myocardial β-agonist receptor density, and components of the receptor-cyclase system in newborn lambs before (n = 6) and after (n = 5) 3 d of continuous isopro-terenol administration (2 μg/kg/min). β-Adrenergic receptors were measured by radioligand binding. Epinephrine dose-response curves were analyzed for the threshold and slope for changes in mean blood pressure, systolic blood pressure, and heart rate versus plasma epinephrine levels. Despite 3 d of continuous isoproterenol infusion, we observed no desensitization of the hemodynamic response to epinephrine. There was a reduction in receptor density when expressed per membrane protein [1553 ± 19.5 (controls) versus 73.2 ± 3.8 fmol/mg protein (agonist exposed), p < 0.05], but no alteration in receptor density when expressed per g cardiac wet weight [258.8 ± 39.9 (controls) versus 406.8 ± 74.0 fmol/g wet weight (agonist exposed)). There was no alteration in agonist affinity or in adenylyl cydase activity after adjustment for membrane protein recovery. Prolonged β-agonist infusion in newborn lambs does not desensitize hemodynamk responses to infused epinephrine. We propose that receptor regulation in developing animals is fundamentally different than in adult animals.
What problem does this paper attempt to address?